P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED

Eitemau Tebyg

• P1473: CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB-ANALYSIS OF THE ACTIVATE TRIAL
  gan: Hanny Al-Samkari, et al.
  Cyhoeddwyd: (2023-08-01)
• P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
  gan: E. J. van Beers, et al.
  Cyhoeddwyd: (2022-06-01)
• Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment
  gan: Hanny Al-Samkari, et al.
  Cyhoeddwyd: (2023-09-01)
• P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL
  gan: Rachael F. Grace, et al.
  Cyhoeddwyd: (2023-08-01)
• P1548: LONG-TERM TREATMENT WITH ORAL MITAPIVAT IS ASSOCIATED WITH NORMALIZATION OF HEMOGLOBIN LEVELS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
  gan: W. Barcellini, et al.
  Cyhoeddwyd: (2022-06-01)